Treasury Chief Reeves Plans Focused Measures on Living Costs in Upcoming Financial Plan
Chancellor Rachel Reeves has announced she is planning "focused action to tackle cost of living challenges" in the forthcoming Budget.
In comments to the BBC, she emphasized that reducing price rises is a shared task of both the administration and the Bank of England.
The UK's price growth is expected to be the highest among the Group of Seven industrialized countries this calendar year and next.
Potential Energy Cost Interventions
Reports indicate the administration could take action to reduce utility costs, such as by slashing the present 5% level of value-added tax charged on energy.
A further approach is to cut some of the policy costs presently included in bills.
Budgetary Limitations and Analyst Predictions
The administration will receive the latest draft from the independent fiscal watchdog, the OBR, on Monday, which will show how much room there is for such measures.
The expectation from the majority of analysts is that the Chancellor will have to announce higher taxes or budget cuts in order to adhere to her voluntary debt limits.
Earlier on Thursday, estimates indicated there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the lower end of forecasts.
"It is a collective job between the Bank of England and the administration to further reduce some of the sources of price increases," Reeves informed reporters in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.
Revenue Commitments and Global Concerns
While much of the focus has been on expected tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her pledge to election pledges not to increase rates on earnings tax, VAT or social security contributions.
She blamed an "uncertain world" with rising international and trade concerns for the fiscal revenue measures, probably to be focused on those "most able to pay."
Global Trade Disputes
Addressing concerns about the UK's trade ties with the Asian nation she said: "The UK's security interests always come first."
Last week's statement by China to strengthen trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led US President the US President to propose an additional 100% tariff on imports from China, increasing the prospect of an full-scale commercial conflict between the two largest economies.
The US Treasury Secretary described the Chinese move "economic coercion" and "a international production control attempt."
Inquired about accepting the US offer to participate in its dispute with the Asian nation, Reeves said she was "very concerned" by China's actions and urged the Chinese government "to avoid restrictions and limit trade."
She said the decision was "bad for the international commerce and causes additional challenges."
"I believe there are sectors where we must address Chinese policies, but there are also valuable chances to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that equilibrium correct."
The Treasury chief also stated she was cooperating with G7 counterparts "on our own essential resources strategy, so that we are more independent."
Health Service Medicine Pricing and Funding
The Chancellor also recognized that the cost the National Health Service pays for drugs could go up as a consequence of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.
A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping operations in the UK, with several blaming the modest returns they are getting.
Last month, the Science Minister said the cost the NHS spends on drugs would have to increase to prevent firms and drug research funding departing from the UK.
Reeves told media: "It has been observed due to the payment system, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other EU nations."
"Our aim is to guarantee that patients receiving care from the National Health Service are able to receive the best life-saving medicines in the globe. And so we are reviewing this situation, and... looking to secure additional capital into the UK."